ADVANCED OXYGEN TECHNOLOGIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ADVANCED OXYGEN TECHNOLOGIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.05
General and administrative	0.01	0	0	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Operating expenses			0.02	0.14	0.02	0.03	0.03	0.03	0.03	0.03
Operating income			0.02	-0.09	0.02		0.01	0.01	0.01	0.02
Interest expense	0.01	0.01	0	0	0	0	0
Interest income								0	0
Other non-operating income					-0	0.05	-0	0	0	0
Pre-tax income	0.01	0.01	0.01	-0.1	0.01	0.07	0.01	0.01	0.01	0.02
Income tax	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	-0.09
Net income	0	0.01	0.01	-0.1	0.01	0.06	0	0.01	0	0.1
EPS, basic	0.00	0.00	0.00	-0.03	0.00	0.02	0.00	0.00	0.00	0.03
EPS, diluted	0.00	0.00	0.00	-0.03	0.00	0.02	0.00	0.00	0.00	0.03
Shares, basic (weighted)	2.29	2.29	2.29	3.06	3.29	3.29	3.29	3.29	3.29	3.29
Shares, diluted (weighted)	2.3	2.3	2.3	3.06	3.3	3.3	3.3	3.3	3.3	3.3

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	0.05	0.05	0.04	0.04	0.05	0.09	0.1	0.09	0.06	0.04
Total current assets	0.05	0.06	0.04	0.04	0.05	0.1	0.11	0.1	0.06	0.04
Property, plant and equipment	0.62	0.63	0.62	0.61	0.65	0.57	0.59	0.58	0.63	0.62
Intangible assets					0.65
Total assets	0.67	0.69	0.66	0.65	0.7	0.66	0.7	0.68	0.69	0.66
Accounts payable	0	0	0	0	0	0	0	0	0	0.01
Deferred revenue			0	0	0	0			0	0
Short-term debt				0.19	0.02	0.02	0.01	0.13	0.13	0.13
Total current liabilities	0.38	0.3	0.3	0.3	0.2	0.21	0.22	0.21	0.15	0.04
Long-term debt				0.04	0.15	0.13		0.13	0	0
Total liabilities	0.38	0.38	0.36	0.35	0.35	0.34	0.35	0.33	0.28	0.16
Total debt				0.19	0.17	0.15	0.13	0.13	0.13	0.13
Paid-in capital	21	21	21	21.1	21.1	21.1	21.1	21.1	21.1	21.1
Retained earnings	-20.7	-20.7	-20.7	-20.8	-20.8	-20.8	-20.8	-20.8	-20.8	-20.6
Other comprehensive income	0.05	0.06	0.05	0.04	0.08	-0.01	0.02	0.01	0.08	0.05
Shareholders' equity	0.29	0.31	0.3	0.31	0.35	0.32	0.35	0.34	0.42	0.49
Total equity	0.29	0.31	0.3	0.31	0.35	0.32	0.35	0.34	0.42	0.49
Total liabilities and equity	0.67	0.69	0.66	0.65	0.7	0.66	0.7	0.68	0.69	0.66
Shares outstanding	2.29	2.29	2.29	3.29	3.29	3.29	3.29	3.29	3.29	3.29

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	0	0.01	0.01	-0.1	-0.01	-0.06	0	0.01	0	0.1
Stock-based compensation				0.11
Deferred income tax					0	0	0	0	0	0
Change in payables	-0	-0	-0	-0	0	-0	0	0	0	0.01
Cash from operations	0.03	0.03	0.02	0.04	0.04	0.09	0.04	0.05	0.04	0.05
Cash from investing				-0
Debt issued	-0.03	-0.03
Debt repaid		-0.03	-0.02	-0.02	-0.02	-0.02	-0.02	-0.01	0	0
Cash from financing	-0.03	-0.03	-0.03	-0.04	-0.03	-0.03	-0.03	-0.05	-0.09	-0.07
Exchange rate effect	0	0	-0	-0	-0		0	-0	0.01	-0
Net change in cash	0	0	-0.01	0	0.01	0.04	0.01	-0.01	-0.04	-0.02
Interest paid	0.01	0.01	0	0	0	0	0	0	0	0
Income taxes paid					0	0.01	0.01	0	0.01	0

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $0.08 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	34.4%	Operating income / revenue.
Pre-tax margin	34.5%	Pre-tax income / revenue.
Net margin	217.0%	Net income / revenue.
Operating cash flow margin	108.3%	Cash from operations / revenue.
Effective tax rate	-529.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	22.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	15.3%	Net income / average total assets.
Return on invested capital (ROIC)	2.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	9.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	6.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	18.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	13.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-0.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	2,388.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	256.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	78.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	27.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	13.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	6.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	18.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	12.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	7.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-5.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-2.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-1.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.11x	Current assets / current liabilities.
Quick ratio	1.07x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.07x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.26x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	19.3%	Total debt / total assets.
Liabilities / assets	24.9%	Total liabilities / total assets.
Net debt	$87.8K	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$3.9K	Current assets - current liabilities.
Tangible book value	$493.6K	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.07x	Revenue / average total assets.
Fixed asset turnover	0.08x	Revenue / average property, plant and equipment.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.03	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$0.03	Net income per basic share, as reported (split-adjusted).
Revenue per share	$0.01	Revenue / diluted weighted shares.
Operating cash flow per share	$0.02	Cash from operations / diluted weighted shares.
Book value per share	$0.15	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.15	Tangible book value / shares outstanding.
Cash per share	$0.01	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$250.3K	Share price x shares outstanding.
Enterprise value	$338.0K	Market cap + total debt - cash - short-term investments.
P/E	2.43x	Market cap / net income. Only when net income is positive.
P/S	5.27x	Market cap / revenue.
P/B	0.51x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.51x	Market cap / tangible book value, when positive.
P/OCF	4.87x	Market cap / cash from operations, when positive.
EV/Sales	7.12x	Enterprise value / revenue.
EV/EBIT	20.7x	Enterprise value / operating income, when both are positive.
Earnings yield	41.1%	Net income / market cap (the inverse of P/E).

What was ADVANCED OXYGEN TECHNOLOGIES INC's revenue in fiscal 2026?

ADVANCED OXYGEN TECHNOLOGIES INC reported revenue of $47.4K for fiscal 2026, 9.2% higher than the year before.

Was ADVANCED OXYGEN TECHNOLOGIES INC profitable in fiscal 2026?

Yes. Net income was $103.0K, a net margin of 217%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ADVANCED OXYGEN TECHNOLOGIES INC